The Impact of Diabetes Type 2 in the Pathogenesis of Benign Prostatic Hyperplasia: A Review

被引:13
|
作者
Stamatiou, K. [1 ]
Lardas, M. [1 ]
Kostakos, E. [1 ]
Koutsonasios, V. [1 ]
Michail, E. [1 ]
机构
[1] Tzane Gen Hosp, Dept Urol, 2 Salepoula St, Piraeus 18536, Greece
关键词
D O I
10.1155/2009/818965
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Introduction. Clinical observation of larger prostate glands in men with diabetes mellitus type 2 led some investigators to hypothesize that an association between these two conditions exists. In fact, both diseases are very common in men as they age and seem to be sharing similar epidemiologic features. Several studies examining the above hypothesis were yielded. Aim. The purpose of this paper is to summarize the existing literature focusing on the coexistence of BPH and diabetes mellitus type 2 and to elucidate whether or not an association among these conditions exists. Methods. We identified studies published from 1990 onwards by searching the MEDLINE database of the National Library of Medicine. Initial search terms were benign prostatic hyperplasia, epidemiology, and risk factor, combined with diet hyperinsulinemia, and diabetes mellitus type 2. Results. Diabetes mellitus type 2 and hyperinsulinemia are quite common conditions and often coexist with BPH. There are several studies (observational, epidemiological, and experimental) examining the association between them in literature. Conclusion. Evidence suggests that an association between BPH and diabetes through a common pathogenic mechanism is possible. The specific pathway interfering in the development of both conditions is still poorly investigated; thus, the exact relationship of BPH to diabetes remains unclear. Copyright (C) 2009 K. Stamatiou et al.
引用
收藏
页数:3
相关论文
共 50 条
  • [1] THE PATHOGENESIS OF BENIGN PROSTATIC HYPERPLASIA
    WILSON, JD
    AMERICAN JOURNAL OF MEDICINE, 1980, 68 (05) : 745 - 756
  • [2] PATHOGENESIS OF BENIGN PROSTATIC HYPERPLASIA
    BOSCH, RJLH
    EUROPEAN UROLOGY, 1991, 20 : 27 - 30
  • [3] Aetiology and pathogenesis of benign prostatic hyperplasia
    Eaton, CL
    CURRENT OPINION IN UROLOGY, 2003, 13 (01) : 7 - 10
  • [4] BENIGN PROSTATIC HYPERPLASIA - PATHOGENESIS AND MEDICAL THERAPY
    GELLER, J
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 1991, 39 (12) : 1208 - 1216
  • [5] Genetic polymorphism and pathogenesis of benign prostatic hyperplasia
    Konwar, Rituraj
    Chattopadhyay, Naibedya
    Bid, Hemant Kumar
    BJU INTERNATIONAL, 2008, 102 (05) : 536 - 543
  • [6] Chronic inflammation in the pathogenesis of benign prostatic hyperplasia
    Fibbi, B.
    Penna, G.
    Morelli, A.
    Adorini, L.
    Maggi, M.
    INTERNATIONAL JOURNAL OF ANDROLOGY, 2010, 33 (03): : 475 - 488
  • [7] Molecular and cellular pathogenesis of benign prostatic hyperplasia
    Lee, KL
    Peehl, DM
    JOURNAL OF UROLOGY, 2004, 172 (05) : 1784 - 1791
  • [8] Cellular senescence in the pathogenesis of benign prostatic hyperplasia
    Castro, P
    Giri, D
    Lamb, D
    Ittmann, M
    PROSTATE, 2003, 55 (01) : 30 - 38
  • [9] STEROID-HORMONES AND THE PATHOGENESIS OF BENIGN PROSTATIC HYPERPLASIA
    GRIFFITHS, K
    EATON, CL
    HARPER, ME
    PEELING, B
    DAVIES, P
    EUROPEAN UROLOGY, 1991, 20 : 68 - 77
  • [10] PATHOGENESIS AND MEDICAL-TREATMENT OF BENIGN PROSTATIC HYPERPLASIA
    GELLER, J
    PROSTATE, 1989, : 95 - 104